These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 16702041)
41. Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists. Malovichko OL; Petrus AS; Krysko AA; Kabanova TA; Andronati SA; Karaseva TL; Kiriyak AV Bioorg Med Chem Lett; 2006 Oct; 16(20):5294-7. PubMed ID: 16919941 [TBL] [Abstract][Full Text] [Related]
42. Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin. Krysko AA; Krysko OL; Kabanova TA; Andronati SA; Kabanov VM Bioorg Med Chem Lett; 2010 Aug; 20(15):4444-6. PubMed ID: 20598885 [TBL] [Abstract][Full Text] [Related]
43. Integrin binding characteristics of the disintegrin-like domain of ADAM-15. Lu D; Chung KF; Xia M; Lu X; Scully M; Kakkar V Thromb Haemost; 2006 Nov; 96(5):642-51. PubMed ID: 17080222 [TBL] [Abstract][Full Text] [Related]
44. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor. Barre DE Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375 [TBL] [Abstract][Full Text] [Related]
45. Isolation and characterization of an anti-leishmanial disintegrin from Cerastes cerastes venom. Allane D; Oussedik-Oumehdi H; Harrat Z; Seve M; Laraba-Djebari F J Biochem Mol Toxicol; 2018 Feb; 32(2):. PubMed ID: 29278277 [TBL] [Abstract][Full Text] [Related]
46. Determination of the structure of two novel echistatin variants and comparison of the ability of echistatin variants to inhibit aggregation of platelets from different species. Chen YL; Huang TF; Chen SW; Tsai IH Biochem J; 1995 Jan; 305 ( Pt 2)(Pt 2):513-20. PubMed ID: 7832768 [TBL] [Abstract][Full Text] [Related]
47. The presence of the WGD motif in CC8 heterodimeric disintegrin increases its inhibitory effect on alphaII(b)beta3, alpha(v)beta3, and alpha5beta1 integrins. Calvete JJ; Fox JW; Agelan A; Niewiarowski S; Marcinkiewicz C Biochemistry; 2002 Feb; 41(6):2014-21. PubMed ID: 11827548 [TBL] [Abstract][Full Text] [Related]
48. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD. Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613 [TBL] [Abstract][Full Text] [Related]
49. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361 [TBL] [Abstract][Full Text] [Related]
50. Novel function of human ADAM15 disintegrin-like domain and its derivatives in platelet aggregation. Jeon OH; Kim D; Choi YJ; Kim SH; Choi WS; Kim DS Thromb Res; 2007; 119(5):609-19. PubMed ID: 16797059 [TBL] [Abstract][Full Text] [Related]
51. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa. Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655 [TBL] [Abstract][Full Text] [Related]
52. Functional mutation of multiple solvent-exposed loops in the Ecballium elaterium trypsin inhibitor-II cystine knot miniprotein. Kimura RH; Jones DS; Jiang L; Miao Z; Cheng Z; Cochran JR PLoS One; 2011 Feb; 6(2):e16112. PubMed ID: 21364742 [TBL] [Abstract][Full Text] [Related]
53. Allosteric regulation of alpha(IIb)beta(3) by beta(3) 95-105. Haas TA Thromb Haemost; 2008 Apr; 99(4):701-10. PubMed ID: 18392328 [TBL] [Abstract][Full Text] [Related]
54. Engineered cystine-knot peptides that bind alpha(v)beta(3) integrin with antibody-like affinities. Silverman AP; Levin AM; Lahti JL; Cochran JR J Mol Biol; 2009 Jan; 385(4):1064-75. PubMed ID: 19038268 [TBL] [Abstract][Full Text] [Related]
55. A novel disintegrin-like domain of a high molecular weight metalloprotease inhibits platelet aggregation. You WK; Jang YJ; Chung KH; Kim DS Biochem Biophys Res Commun; 2003 Sep; 309(3):637-42. PubMed ID: 12963038 [TBL] [Abstract][Full Text] [Related]
56. Elegantin and albolabrin purified peptides from viper venoms: homologies with the RGDS domain of fibrinogen and von Willebrand factor. Williams J; Rucinski B; Holt J; Niewiarowski S Biochim Biophys Acta; 1990 May; 1039(1):81-9. PubMed ID: 2191722 [TBL] [Abstract][Full Text] [Related]
57. The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides. Christmann A; Walter K; Wentzel A; Krätzner R; Kolmar H Protein Eng; 1999 Sep; 12(9):797-806. PubMed ID: 10506290 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852. Wittig K; Rothe G; Schmitz G Thromb Haemost; 1998 Mar; 79(3):625-30. PubMed ID: 9531053 [TBL] [Abstract][Full Text] [Related]
59. Investigation of the role of adjacent amino acids to the 313-320 sequence of the alphaIIb subunit on platelet activation and fibrinogen binding to alphaIIbbeta3. Mitsios JV; Stamos G; Rodis FI; Tsironis LD; Stanica MR; Sakarellos C; Tsoukatos D; Tsikaris V; Tselepis AD Platelets; 2006 Aug; 17(5):277-82. PubMed ID: 16928597 [TBL] [Abstract][Full Text] [Related]
60. NMR solution structure of the non-RGD disintegrin obtustatin. Paz Moreno-Murciano M; Monleón D; Marcinkiewicz C; Calvete JJ; Celda B J Mol Biol; 2003 May; 329(1):135-45. PubMed ID: 12742023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]